Overview

Effects of Isotretinoin on CYP2D6 Activity

Status:
Active, not recruiting
Trial end date:
2026-07-26
Target enrollment:
Participant gender:
Summary
Specific Aim: To investigate if isotretinoin (13-cis-retinoic acid) administration decreases CYP2D6 activity in adolescent patients.
Phase:
Phase 4
Details
Lead Sponsor:
University of Washington
Collaborator:
National Institute of General Medical Sciences (NIGMS)
Treatments:
Dextromethorphan
Isotretinoin